Pediatric Crohn disease: Clinical and genetic characteristics in Taiwan

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 3, 2007, Pages 342-346

  Hsiao, Cheng Hui ^a   Wei, Shu Chen ^a   Wong, Jau Min ^a   Lai, Hong Shiee ^a   Chang, Mei Hwei ^a   Ni, Yen Hsuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Children; Crohn disease; NOD2 CARD15; Toll like receptor 4

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLITIS; COLON; CROHN DISEASE; DNA EXTRACTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC TRAIT; HOSPITALIZATION; HUMAN; ILEUM MUCOSA; MALE; PEDIATRICS; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TAIWAN; UNIVERSITY HOSPITAL; UPPER GASTROINTESTINAL TRACT; CHILD; GENETICS; GENOTYPE; INFANT; PATHOLOGY;

FISTULA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; TAIWAN;

EID: 33847757832     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31802c6997     Document Type: Article

References (29)

1. Sartor RB. Microbial Factors in the Pathogenesis of Crohn's Disease, Ulcerative Colitis, and Experimental Intestinal Inflammation. Philadelphia: WB Saunders; 2000.
2. Dianda L, Hanby AM, Wright LA, et al. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91-7.
3. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
7. Cario E, Rosenberg IM, Brandwein SL, et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000;164:966-72.
8. Nomura F, Akashi S, Sakao Y, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface toll-like receptor 4 expression. J Immunol 2000;164:3476-9.
9. Brand S, Staudinger T, Schnitzler F, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis 2005;11:645-52.
10. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
11. Bairead E, Harmon DL, Curtis AM, et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003;11:237-44.
12. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
13. Hugot JP, Zouali H, Lesage S. Lessons to be learned from the NOD2 gene in Crohn's disease. Eur J Gastroenterol Hepatol 2003;15: 593-7.
14. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359:1661-5.
15. Vermeire S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74-83.
16. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
17. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003;11: 6-16.
18. Guo QS, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol 2004;10: 1069-71.
19. Kugathasan S, Loizides A, Babusukumar U, et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and white children with Crohn's disease. Inflamm Bowel Dis 2005;11:631-8.
20. Tsai CH, Chen HL, Ni YH, et al. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 2004;103:685-91.
21. Morson BC. Histopathology of Crohn's disease. Proc R Soc Med 1968;61:79-81.
22. Langholz E, Munkholm P, Krasilnikoff PA, et al. Inflammatory bowel disease with onset in childhood: clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47.
23. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
24. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
25. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001;31:22-4.
26. Polito JM, Childs B, Mellits ED, et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-6.
27. Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. Br Med J 1994;308:1259-63.
28. Brant SR, Panhuysen CIM, Bailey-Wilson JE, et al. Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology 2000;119:1483-90.
29. Nakajima A, Matsuhashi N, Kodama T, et al. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995;109:1462-7.